← back to search

Franck J. Barrat

Hospital for Special Surgery · US
Area of research
Immunology
Research interest
Research interests include Immune Response and Inflammation, Immune Cell Function and Interaction, Immunotherapy and Immune Responses, and T-cell and B-cell Immunology.
h-index
47
citations
17,975
works
95
NIH funding
primary concept
Biology
email

Recent publications

RNA N-glycosylation enables immune evasion and homeostatic efferocytosis
Nature 2025cited by 33position: middledoi
Modulation of plasmacytoid dendritic cells response in inflammation and autoimmunity
Immunological Reviews 2024cited by 23position: lastdoi
Altered X-chromosome inactivation of the TLR7/8 locus and heterogeneity of pDCs in systemic sclerosis
The Journal of Experimental Medicine 2024cited by 20position: lastdoi
Epigenetic memory of coronavirus infection in innate immune cells and their progenitors
Cell 2023cited by 260position: middledoi
TLR8 escapes X chromosome inactivation in human monocytes and CD4+ T cells
Biology of Sex Differences 2023cited by 47position: middledoi
Reclassification of plasmacytoid dendritic cells as innate lymphocytes is premature
Nature reviews. Immunology 2023cited by 34position: middledoi
TLR9 ligand sequestration by chemokine CXCL4 negatively affects central B cell tolerance
The Journal of Experimental Medicine 2023cited by 16position: middledoi
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
The Journal of Immunology 2023cited by 1position: lastdoi
Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19
Science Immunology 2022cited by 85position: lastdoi
Chronic activation of pDCs in autoimmunity is linked to dysregulated ER stress and metabolic responses
The Journal of Experimental Medicine 2022cited by 62position: lastdoi
Tumor-Derived Lysophosphatidic Acid Blunts Protective Type I Interferon Responses in Ovarian Cancer
Cancer Discovery 2022cited by 58position: middledoi
Chemokines form nanoparticles with DNA and can superinduce TLR-driven immune inflammation
The Journal of Experimental Medicine 2022cited by 43position: lastdoi
CXCL4 synergizes with TLR8 for TBK1-IRF5 activation, epigenomic remodeling and inflammatory response in human monocytes
Nature Communications 2022cited by 42position: middledoi
Interferon target-gene expression and epigenomic signatures in health and disease
Nature Immunology 2019cited by 537position: firstdoi
Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
Nature Medicine 2012cited by 416position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marie Dominique Ah Kioon · Hospital for Special Surgery6 papers (2022–2025)Lionel B. Ivashkiv · Hospital for Special Surgery5 papers (2019–2023)Vidyanath Chaudhary · Hospital for Special Surgery4 papers (2022–2024)Paôline Laurent · Hospital for Special Surgery4 papers (2022–2024)Chao Yang · First People's Hospital of Yunnan Province4 papers (2022–2023)Yong Du · Sun Yat-sen University4 papers (2022–2024)Mary K. Crow · Cornell University3 papers (2019–2024)Michael Pierides · Hospital for Special Surgery2 papers (2022–2024)Lucía Carrau · New York University2 papers (2022–2023) · 2 papers (2023–2024)Yaron Bram · Cornell University2 papers (2022–2023)Benjamin E. Nilsson-Payant · Karolinska Institutet2 papers (2022–2023)Robert E. Schwartz · Cornell University2 papers (2022–2023)Juan R. Cubillos‐Ruiz · Cornell University2 papers (2022–2022)Benjamin R. tenOever · Sinai Hospital2 papers (2022–2023)Olivier Elemento · Cornell University2 papers (2022–2023)Sung‐Min Hwang · Cornell University2 papers (2022–2022)Jessica Gordon · Hospital for Special Surgery2 papers (2022–2024)Julie Chaumeil · New York University2 papers (2023–2024) · 2 papers (2023–2024)